Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2008 1
2009 2
2010 1
2011 2
2012 1
2013 1
2014 2
2016 1
2017 1
2018 1
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
Evolution and Virulence of Influenza A Virus Protein PB1-F2.
Kamal RP, Alymova IV, York IA. Kamal RP, et al. Among authors: alymova iv. Int J Mol Sci. 2017 Dec 29;19(1):96. doi: 10.3390/ijms19010096. Int J Mol Sci. 2017. PMID: 29286299 Free PMC article. Review.
Influenza virus N-linked glycosylation and innate immunity.
York IA, Stevens J, Alymova IV. York IA, et al. Among authors: alymova iv. Biosci Rep. 2019 Jan 8;39(1):BSR20171505. doi: 10.1042/BSR20171505. Print 2019 Jan 31. Biosci Rep. 2019. PMID: 30552137 Free PMC article. Review.
Loss of the N-linked glycan at residue 173 of human parainfluenza virus type 1 hemagglutinin-neuraminidase exposes a second receptor-binding site.
Alymova IV, Taylor G, Mishin VP, Watanabe M, Murti KG, Boyd K, Chand P, Babu YS, Portner A. Alymova IV, et al. J Virol. 2008 Sep;82(17):8400-10. doi: 10.1128/JVI.00474-08. Epub 2008 Jun 25. J Virol. 2008. PMID: 18579600 Free PMC article.
N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site.
Mishin VP, Watanabe M, Taylor G, Devincenzo J, Bose M, Portner A, Alymova IV. Mishin VP, et al. Among authors: alymova iv. J Virol. 2010 Mar;84(6):3094-100. doi: 10.1128/JVI.02331-09. Epub 2010 Jan 6. J Virol. 2010. PMID: 20053750 Free PMC article.
Virulent PB1-F2 residues: effects on fitness of H1N1 influenza A virus in mice and changes during evolution of human influenza A viruses.
Alymova IV, McCullers JA, Kamal RP, Vogel P, Green AM, Gansebom S, York IA. Alymova IV, et al. Sci Rep. 2018 May 10;8(1):7474. doi: 10.1038/s41598-018-25707-y. Sci Rep. 2018. PMID: 29749408 Free PMC article.
Glycosylation changes in the globular head of H3N2 influenza hemagglutinin modulate receptor binding without affecting virus virulence.
Alymova IV, York IA, Air GM, Cipollo JF, Gulati S, Baranovich T, Kumar A, Zeng H, Gansebom S, McCullers JA. Alymova IV, et al. Sci Rep. 2016 Oct 31;6:36216. doi: 10.1038/srep36216. Sci Rep. 2016. PMID: 27796371 Free PMC article.
Receptor-binding specificity of the human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein.
Alymova IV, Portner A, Mishin VP, McCullers JA, Freiden P, Taylor GL. Alymova IV, et al. Glycobiology. 2012 Feb;22(2):174-80. doi: 10.1093/glycob/cwr112. Epub 2011 Aug 16. Glycobiology. 2012. PMID: 21846691 Free PMC article.
Non-avian animal reservoirs present a source of influenza A PB1-F2 proteins with novel virulence-enhancing markers.
Alymova IV, York IA, McCullers JA. Alymova IV, et al. PLoS One. 2014 Nov 4;9(11):e111603. doi: 10.1371/journal.pone.0111603. eCollection 2014. PLoS One. 2014. PMID: 25368997 Free PMC article.
A novel cytotoxic sequence contributes to influenza A viral protein PB1-F2 pathogenicity and predisposition to secondary bacterial infection.
Alymova IV, Samarasinghe A, Vogel P, Green AM, Weinlich R, McCullers JA. Alymova IV, et al. J Virol. 2014 Jan;88(1):503-15. doi: 10.1128/JVI.01373-13. Epub 2013 Oct 30. J Virol. 2014. PMID: 24173220 Free PMC article.
Efficacy of the novel parainfluenza virus haemagglutinin-neuraminidase inhibitor BCX 2798 in mice - further evaluation.
Alymova IV, Watanabe M, Boyd KL, Chand P, Babu YS, Portner A. Alymova IV, et al. Antivir Ther. 2009;14(7):891-8. doi: 10.3851/IMP1420. Antivir Ther. 2009. PMID: 19918093 Free PMC article.
14 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page